136 related articles for article (PubMed ID: 3053229)
1. The use of primary cultures of adult rat hepatocytes to study induction of enzymes and DNA synthesis: effect of nafenopin and electroporation.
Muakkassah-Kelly SF; Bieri F; Waechter F; Bentley P; Stäubli W
Experientia; 1988 Oct; 44(10):823-7. PubMed ID: 3053229
[TBL] [Abstract][Full Text] [Related]
2. Long-term maintenance of hepatocytes in primary culture in the presence of DMSO: further characterization and effect of nafenopin, a peroxisome proliferator.
Muakkassah-Kelly SF; Bieri F; Waechter F; Bentley P; Stäubli W
Exp Cell Res; 1987 Jul; 171(1):37-51. PubMed ID: 3622636
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of DNA synthesis but not of peroxisomal beta-oxidation by nafenopin in primary cultures of marmoset hepatocytes.
Bieri F; Stäubli W; Waechter F; Muakkassah-Kelly S; Bentley P
Cell Biol Int Rep; 1988 Dec; 12(12):1077-87. PubMed ID: 3147145
[TBL] [Abstract][Full Text] [Related]
4. Use of primary cultures of adult rat hepatocytes to investigate mechanisms of action of nafenopin, a hepatocarcinogenic peroxisome proliferator.
Bieri F; Bentley P; Waechter F; Stäubli W
Carcinogenesis; 1984 Aug; 5(8):1033-9. PubMed ID: 6146407
[TBL] [Abstract][Full Text] [Related]
5. An in vitro model of rodent nongenotoxic hepatocarcinogenesis.
James NH; Molloy CA; Soames AR; French NJ; Roberts RA
Exp Cell Res; 1992 Dec; 203(2):407-19. PubMed ID: 1281111
[TBL] [Abstract][Full Text] [Related]
6. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes.
James NH; Roberts RA
Carcinogenesis; 1994 Dec; 15(12):2687-94. PubMed ID: 8001222
[TBL] [Abstract][Full Text] [Related]
7. Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro.
Hasmall SC; West DA; Olsen K; Roberts RA
Carcinogenesis; 2000 Dec; 21(12):2159-65. PubMed ID: 11133804
[TBL] [Abstract][Full Text] [Related]
8. Mouse hepatocyte response to peroxisome proliferators: dependency on hepatic nonparenchymal cells and peroxisome proliferator activated receptor alpha (PPARalpha).
Hasmall S; James N; Hedley K; Olsen K; Roberts R
Arch Toxicol; 2001 Aug; 75(6):357-61. PubMed ID: 11570693
[TBL] [Abstract][Full Text] [Related]
9. The peroxisome proliferator nafenopin does not suppress hepatocyte apoptosis in guinea-pig liver in vivo nor in human hepatocytes in vitro.
Hasmall SC; James NH; Soames AR; Roberts RA
Arch Toxicol; 1998 Dec; 72(12):777-83. PubMed ID: 9950074
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte spheroids: prolonged hepatocyte viability for in vitro modeling of nongenotoxic carcinogenesis.
Roberts RA; Soames AR
Fundam Appl Toxicol; 1993 Aug; 21(2):149-58. PubMed ID: 8405777
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of mature TGF beta 1 correlates with the suppression of rat hepatocyte apoptosis by the peroxisome proliferator, nafenopin.
Strange J; Roberts RA
Mutat Res; 1996 Nov; 372(1):107-13. PubMed ID: 9003537
[TBL] [Abstract][Full Text] [Related]
12. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis.
James NH; Roberts RA
Carcinogenesis; 1996 Aug; 17(8):1623-32. PubMed ID: 8761418
[TBL] [Abstract][Full Text] [Related]
13. Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin.
West DA; James NH; Cosulich SC; Holden PR; Brindle R; Rolfe M; Roberts RA
Hepatology; 1999 Dec; 30(6):1417-24. PubMed ID: 10573520
[TBL] [Abstract][Full Text] [Related]
14. Assessment of peroxisome proliferation and liver growth-stimulating potential by nondirectly genotoxic compounds in cultured hepatocytes.
Bieri F; Stäubli W; Kelly S; Waechter F; Bentley P
Mol Toxicol; 1987-1988 Fall; 1(4):439-44. PubMed ID: 3151502
[TBL] [Abstract][Full Text] [Related]
15. The rodent nongenotoxic hepatocarcinogen and peroxisome proliferator nafenopin inhibits intercellular communication in rat but not guinea-pig hepatocytes, perturbing S-phase but not apoptosis.
Elcock FJ; Chipman JK; Roberts RA
Arch Toxicol; 1998 Jun; 72(7):439-44. PubMed ID: 9708883
[TBL] [Abstract][Full Text] [Related]
16. Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone.
Webb SJ; Xiao GH; Geoghegan TE; Prough RA
Mol Pharmacol; 1996 Feb; 49(2):276-87. PubMed ID: 8632760
[TBL] [Abstract][Full Text] [Related]
17. Induction of acyl-CoA oxidase and cytochrome P450IVA1 RNA in rat primary hepatocyte culture by peroxisome proliferators.
Bell DR; Elcombe CR
Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):249-53. PubMed ID: 1720616
[TBL] [Abstract][Full Text] [Related]
18. Role of fatty acyl coenzyme A oxidase in the efflux of oxidized glutathione from perfused livers of rats treated with the peroxisome proliferator nafenopin.
Conway JG; Neptun DA; Garvey LK; Popp JA
Cancer Res; 1987 Sep; 47(18):4795-800. PubMed ID: 3621175
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of differential protein expression in primary hepatocytes induced by EGF, tumour necrosis factor alpha or the peroxisome proliferator nafenopin.
Chevalier S; Macdonald N; Tonge R; Rayner S; Rowlinson R; Shaw J; Young J; Davison M; Roberts RA
Eur J Biochem; 2000 Aug; 267(15):4624-34. PubMed ID: 10903494
[TBL] [Abstract][Full Text] [Related]
20. Nafenopin, a peroxisome proliferator, depletes hepatic vitamin E content and elevates plasma oxidised glutathione levels in rats.
Lake BG; Gray TJ; Körösi SA; Walters DG
Toxicol Lett; 1989 Feb; 45(2-3):221-9. PubMed ID: 2919403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
